{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:42:35Z","timestamp":1793169755825,"version":"4.5.0"},"reference-count":104,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2025.2848","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T06:10:05Z","timestamp":1744697405000},"page":"1-11","source":"Crossref","is-referenced-by-count":15,"title":["Research progress on the impact of opioids on the tumor immune microenvironment (Review)"],"prefix":"10.3892","volume":"22","author":[{"given":"Yuancheng","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, (Institute of Radiation Medicine), Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 251016, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Li","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medicine of Binzhou Medical University, Anesthesiology, Binzhou Medical University, Yantai, Shandong 264003, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanji","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudong","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanwang","family":"Miao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250117, P.R.\u00a0China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"key20250513105852_b1-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.6004\/jnccn.2010.0077","article-title":"Review of the role of opioids in cancer pain","volume":"8","author":"Trescot","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"key20250513105852_b2-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/JCO.22.02198","article-title":"Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline","volume":"41","author":"Paice","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20250513105852_b3-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","article-title":"Management of cancer pain in adult patients: ESMO clinical practice guidelines","volume":"29 (Suppl 4)","author":"Fallon","year":"2018","journal-title":"Ann Oncol"},{"key":"key20250513105852_b4-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/j.pain.0000000000001736","article-title":"Pain, opioid therapy, and survival: A needed discussion","volume":"161","author":"Novy","year":"2020","journal-title":"Pain"},{"key":"key20250513105852_b5-MCO-22-6-02848","first-page":"216","article-title":"Breast cancer pain management-A review of current & novel therapies","volume":"139","author":"Satija","year":"2014","journal-title":"Indian J Med Res"},{"key":"key20250513105852_b6-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s10620-017-4488-z","article-title":"Pain in patients with pancreatic cancer: Prevalence, mechanisms, management and future developments","volume":"62","author":"Koulouris","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"102","key":"key20250513105852_b7-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-102","article-title":"Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008","volume":"7","author":"Montazeri","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"key20250513105852_b8-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.3390\/curroncol30070500","article-title":"Cancer pain management: A narrative review of current concepts, strategies, and techniques","volume":"30","author":"Mestdagh","year":"2023","journal-title":"Curr Oncol"},{"key":"key20250513105852_b9-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11864-023-01091-2","article-title":"Effects of opioids on immune and endocrine function in patients with cancer pain","volume":"24","author":"Bradley","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"116665","key":"key20250513105852_b10-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116665","article-title":"Effects of opioid drugs on immune function in cancer patients","volume":"175","author":"Li","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"key20250513105852_b11-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1177\/10738584211030493","article-title":"The interplay between chronic pain, opioids, and the immune system","volume":"28","author":"Malafoglia","year":"2022","journal-title":"Neuroscientist"},{"key":"key20250513105852_b12-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system-friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br J Pharmacol"},{"key":"key20250513105852_b13-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.cell.2022.12.026","article-title":"Structures of the entire human opioid receptor family","volume":"186","author":"Wang","year":"2023","journal-title":"Cell"},{"key":"key20250513105852_b14-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev.biochem.73.011303.073940","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu Rev Med"},{"issue":"4257","key":"key20250513105852_b15-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25184257","article-title":"Biased opioid ligands","volume":"25","author":"Faouzi","year":"2020","journal-title":"Molecules"},{"key":"key20250513105852_b16-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"12512","DOI":"10.1073\/pnas.0905874106","article-title":"Distinct opioid circuits determine the palatability and the desirability of rewarding events","volume":"106","author":"Wassum","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20250513105852_b17-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1124\/pr.112.007138","article-title":"Mu Opioids and their receptors: Evolution of a concept","volume":"65","author":"Pasternak","year":"2013","journal-title":"Pharmacol Rev"},{"key":"key20250513105852_b18-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1177\/0897190017732263","article-title":"Peripherally acting \u00b5-opioid receptor antagonists for the treatment of opioid-related side effects: Mechanism of action and clinical implications","volume":"31","author":"Streicher","year":"2018","journal-title":"J Pharm Pract"},{"issue":"44","key":"key20250513105852_b19-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12560","article-title":"Opioids in cancer: The \u03baopioid receptor (Review)","volume":"25","author":"Zhou","year":"2022","journal-title":"Mol Med Rep"},{"key":"key20250513105852_b20-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jcpt.12244","article-title":"Delta opioid agonists: A concise update on potential therapeutic applications","volume":"40","author":"Peppin","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"key20250513105852_b21-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s40429-022-00407-w","article-title":"The role of hippocampus in memory reactivation: An implication for a therapeutic target against opioid use disorder","volume":"9","author":"Dai","year":"2022","journal-title":"Curr Addict Rep"},{"key":"key20250513105852_b22-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/bph.12573","article-title":"\u03ba Opioid receptor ligands regulate angiogenesis in development and in tumours","volume":"172","author":"Yamamizu","year":"2015","journal-title":"Br J Pharmacol"},{"key":"key20250513105852_b23-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/jcrt.JCRT_862_16","article-title":"Oxidative stress and its role in cancer","volume":"17","author":"Jelic","year":"2021","journal-title":"J Cancer Res Ther"},{"issue":"8321","key":"key20250513105852_b24-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27238321","article-title":"Effects of different opioid drugs on oxidative status and proteasome activity in SH-SY5Y cells","volume":"27","author":"Rullo","year":"2022","journal-title":"Molecules"},{"issue":"119469","key":"key20250513105852_b25-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119469","article-title":"Role of TRPA1 expressed in bone tissue and the antinociceptive effect of the TRPA1 antagonist repeated administration in a breast cancer pain model","volume":"276","author":"de Almeida","year":"2021","journal-title":"Life Sci"},{"key":"key20250513105852_b26-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/1570193X113106660031","article-title":"Morphine as a potential oxidative stress-causing agent","volume":"10","author":"Skrabalova","year":"2013","journal-title":"Mini Rev Org Chem"},{"key":"key20250513105852_b27-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"16884","DOI":"10.1074\/jbc.RA119.009592","article-title":"Reactive oxygen species (ROS) generation is stimulated by \u03ba opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation","volume":"294","author":"Schattauer","year":"2019","journal-title":"J Biol Chem"},{"key":"key20250513105852_b28-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: How are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"issue":"14","key":"key20250513105852_b29-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3163-5-14","article-title":"Reactive oxygen species: Role in the development of cancer and various chronic conditions","volume":"5","author":"Waris","year":"2006","journal-title":"J Carcinog"},{"key":"key20250513105852_b30-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1111\/bph.13903","article-title":"Influence of opioids on immune function in patients with cancer pain: From bench to bedside","volume":"175","author":"Boland","year":"2018","journal-title":"Br J Pharmacol"},{"key":"key20250513105852_b31-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00540-012-1472-9","article-title":"Dual modulation of the T-cell receptor-activated signal transduction pathway by morphine in human T lymphocytes","volume":"27","author":"Mizota","year":"2013","journal-title":"J Anesth"},{"key":"key20250513105852_b32-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/107999099313767","article-title":"Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: A role in natural killer and T cell suppression","volume":"19","author":"Gomez-Flores","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"key20250513105852_b33-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/156720206778018767","article-title":"Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells","volume":"3","author":"Chen","year":"2006","journal-title":"Curr Neurovasc Res"},{"issue":"2904","key":"key20250513105852_b34-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02904","article-title":"The role of opioid receptors in immune system function","volume":"10","author":"Eisenstein","year":"2019","journal-title":"Front Immunol"},{"key":"key20250513105852_b35-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s12094-018-1974-5","article-title":"The dual effect of morphine on tumor development","volume":"21","author":"Tuerxun","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"key20250513105852_b36-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s12094-017-1796-x","article-title":"Morphine: Double-faced roles in the regulation of tumor development","volume":"20","author":"Zhang","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"111","key":"key20250513105852_b37-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01107-w","article-title":"Targeting the mu-Opioid receptor for cancer treatment","volume":"23","author":"Zhang","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"key20250513105852_b38-MCO-22-6-02848","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/bjaceaccp\/mku041","article-title":"Opioid receptors","volume":"15","author":"McDonald","year":"2015","journal-title":"BJA Education"},{"issue":"161508","key":"key20250513105852_b39-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/161508","article-title":"Morphine promotes tumor angiogenesis and increases breast cancer progression","volume":"2015","author":"Bimonte","year":"2015","journal-title":"Biomed Res Int"},{"issue":"176637","key":"key20250513105852_b40-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176637","article-title":"Immunosuppressive effects of morphine on macrophage polarization and function","volume":"975","author":"Malik","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"key20250513105852_b41-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1002\/jcb.25895","article-title":"Macrophage polarization: Anti-cancer strategies to target tumor-associated macrophage in breast cancer","volume":"118","author":"Tariq","year":"2017","journal-title":"J Cell Biochem"},{"key":"key20250513105852_b42-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s11033-010-0222-z","article-title":"The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line","volume":"38","author":"Gach","year":"2011","journal-title":"Mol Biol Rep"},{"key":"key20250513105852_b43-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"576","DOI":"10.21873\/invivo.12740","article-title":"The effects of analgesics on the migration of pancreatic cancer cells","volume":"36","author":"Malsy","year":"2022","journal-title":"In Vivo"},{"key":"key20250513105852_b44-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.bbamcr.2013.12.006","article-title":"Nitric oxide-matrix metaloproteinase-9 interactions: Biological and pharmacological significance: NO and MMP-9 interactions","volume":"1843","author":"O'Sullivan","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"key20250513105852_b45-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.fct.2013.06.013","article-title":"ROS-major mediators of extracellular matrix remodeling during tumor progression","volume":"61","author":"Nikitovic","year":"2013","journal-title":"Food Chem Toxicol"},{"issue":"3249","key":"key20250513105852_b46-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3390\/s18103249","article-title":"Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent advances","volume":"18","author":"Huang","year":"2018","journal-title":"Sensors (Basel)"},{"key":"key20250513105852_b47-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.18632\/oncotarget.1932","article-title":"Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer","volume":"5","author":"Mehner","year":"2014","journal-title":"Oncotarget"},{"issue":"24233","key":"key20250513105852_b48-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75089-7","article-title":"Bidirectional effects of morphine on pancreatic cancer progression via the p38\/JNK pathway","volume":"14","author":"Ning","year":"2024","journal-title":"Sci Rep"},{"key":"key20250513105852_b49-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/0886022X.2016.1256322","article-title":"Morphine enhances renal cell carcinoma aggressiveness through promotes survivin level","volume":"39","author":"Ma","year":"2016","journal-title":"Ren Fail"},{"issue":"9364365","key":"key20250513105852_b50-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9364365","article-title":"Morphine in combination with ketamine improves cervical cancer pain and suppresses immune function via the JAK3\/STAT5 pathway","volume":"2022","author":"Jiang","year":"2022","journal-title":"Pain Res Manag"},{"issue":"622","key":"key20250513105852_b51-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02334-8","article-title":"Morphine promotes the malignant biological behavior of non-small cell lung cancer cells through the MOR\/Src\/mTOR pathway","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"key20250513105852_b52-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2353\/ajpath.2010.090621","article-title":"Morphine suppresses tumor angiogenesis through a HIF-1\u03b1\/p38MAPK pathway","volume":"177","author":"Koodie","year":"2010","journal-title":"Am J Pathol"},{"key":"key20250513105852_b53-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.neo.2020.12.011","article-title":"Opioids drive breast cancer metastasis through the \u03b4-opioid receptor and oncogenic STAT3","volume":"23","author":"Tripolt","year":"2021","journal-title":"Neoplasia"},{"key":"key20250513105852_b54-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.3892\/or.2016.5109","article-title":"Upregulation and activation of \u03b4opioid receptors promotes the progression of human breast cancer","volume":"36","author":"Wei","year":"2016","journal-title":"Oncol Rep"},{"key":"key20250513105852_b55-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0963689718811060","article-title":"Historical review: Opiate addiction and opioid receptors","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Transplant"},{"issue":"856672","key":"key20250513105852_b56-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.856672","article-title":"Traumatic stress-induced vulnerability to addiction: Critical role of the dynorphin\/kappa opioid receptor system","volume":"13","author":"Leconte","year":"2022","journal-title":"Front Pharmacol"},{"issue":"210","key":"key20250513105852_b57-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-021-01429-z","article-title":"The expression of kappa-opioid receptor promotes the migration of breast cancer cells in vitro","volume":"21","author":"Li","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"key20250513105852_b58-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1111\/j.1476-5381.2011.01513.x","article-title":"Opioids and the immune system: What is their mechanism of action?","volume":"164","author":"Eisenstein","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"92","key":"key20250513105852_b59-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-022-00632-z","article-title":"Morphine suppresses the immune function of lung cancer by up-regulating MAEL expression","volume":"23","author":"Wang","year":"2022","journal-title":"BMC Pharmacol Toxicol"},{"key":"key20250513105852_b60-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4049\/jimmunol.180.5.3594","article-title":"Morphine induces defects in early response of alveolar macrophages to streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling1","volume":"180","author":"Wang","year":"2008","journal-title":"J Immunol"},{"key":"key20250513105852_b61-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"10225","DOI":"10.1074\/jbc.M110.188680","article-title":"morphine inhibits murine dendritic cell IL-23 production by modulating toll-like receptor 2 and Nod2 signaling","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"issue":"156737","key":"key20250513105852_b62-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156737","article-title":"Morphine induces inflammatory responses via both TLR4 and cGAS-STING signaling pathways","volume":"183","author":"Xie","year":"2024","journal-title":"Cytokine"},{"issue":"111335","key":"key20250513105852_b63-MCO-22-6-02848","article-title":"Morphine acts via TLR4 resulting in neuroinflammation and immunosuppression","volume":"186","author":"Malik","year":"2024","journal-title":"Med Hypotheses"},{"key":"key20250513105852_b64-MCO-22-6-02848","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.160.4.1886","article-title":"Morphine enhances macrophage apoptosis","volume":"160","author":"Singhal","year":"1998","journal-title":"J Immunol"},{"issue":"714","key":"key20250513105852_b65-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.10146","article-title":"Morphine enhances LPSinduced macrophage apoptosis through a PPAR\u03b3dependent mechanism","volume":"22","author":"Lin","year":"2021","journal-title":"Exp Ther Med"},{"key":"key20250513105852_b66-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jneuroim.2005.11.009","article-title":"Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell","volume":"173","author":"Saurer","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"123","key":"key20250513105852_b67-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-021-01121-y","article-title":"New Insights on Tramadol and Immunomodulation","volume":"23","author":"Saeed","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"key20250513105852_b68-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1213\/ANE.0000000000004058","article-title":"Suppression of human natural killer cells by different classes of opioids","volume":"128","author":"Maher","year":"2019","journal-title":"Anesth Analg"},{"issue":"11389","key":"key20250513105852_b69-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1038\/srep11389","article-title":"Morphine modulates interleukin-4- or breast cancer cell-induced pro-metastatic activation of macrophages","volume":"5","author":"Khabbazi","year":"2015","journal-title":"Sci Rep"},{"issue":"3213","key":"key20250513105852_b70-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1038\/srep03213","article-title":"\u043a Opioids inhibit tumor angiogenesis by suppressing VEGF signaling","volume":"3","author":"Yamamizu","year":"2013","journal-title":"Sci Rep"},{"key":"key20250513105852_b71-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"970","DOI":"10.7150\/ijms.20064","article-title":"The effects of perioperative anesthesia and analgesia on immune function in patients undergoing breast cancer resection: A prospective randomized study","volume":"14","author":"Cho","year":"2017","journal-title":"Int J Med Sci"},{"issue":"115462","key":"key20250513105852_b72-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115462","article-title":"Activation of kappa opioid receptor (KOR) inhibits estrogen receptor (ER)-positive breast cancer through the KOR-ER-XBP1 pathway","volume":"167","author":"Shi","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"666446","key":"key20250513105852_b73-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.666446","article-title":"Morphine suppresses liver cancer cell tumor properties in vitro and in vivo","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"},{"key":"key20250513105852_b74-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1007\/s00210-023-02871-1","article-title":"Tramadol suppresses growth of orthotopic liver tumors via promoting M1 macrophage polarization in the tumor microenvironment","volume":"397","author":"Wang","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"key20250513105852_b75-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4097\/kja.d.18.00217","article-title":"Designing the ideal perioperative pain management plan starts with multimodal analgesia","volume":"71","author":"Schwenk","year":"2018","journal-title":"Korean J Anesthesiol"},{"key":"key20250513105852_b76-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0165-5728(95)00171-9","article-title":"Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (\u00b5-, kappa-, and delta-) selective agonists","volume":"65","author":"Morgan","year":"1996","journal-title":"J Neuroimmunol"},{"key":"key20250513105852_b77-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"882","DOI":"10.4049\/jimmunol.0802763","article-title":"Mechanisms of opioid-mediated inhibition of human T cell receptor signaling","volume":"183","author":"B\u00f6rner","year":"2009","journal-title":"J Immunol"},{"key":"key20250513105852_b78-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1213\/01.ANE.0000078586.82810.3B","article-title":"The effects of postoperative pain management on immune response to surgery","volume":"93","author":"Beilin","year":"2003","journal-title":"Anesth Analg"},{"key":"key20250513105852_b79-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bja.2021.12.001","article-title":"Buprenorphine: A treatment and cause of opioid-induced respiratory depression","volume":"128","author":"Dahan","year":"2022","journal-title":"Br J Anaesth"},{"key":"key20250513105852_b80-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","article-title":"Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl","volume":"151","author":"Kiyatkin","year":"2019","journal-title":"Neuropharmacology"},{"key":"key20250513105852_b81-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1111\/bcp.15281","article-title":"Immunomodulatory effects of pharmaceutical opioids and antipyretic analgesics: Mechanisms and relevance to infection","volume":"88","author":"Abdel Shaheed","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"key20250513105852_b82-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jpain.2011.11.004","article-title":"Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: Prevalence and risk factors","volume":"13","author":"Saunders","year":"2012","journal-title":"J Pain"},{"key":"key20250513105852_b83-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11916-011-0201-7","article-title":"Pain management in patients with cancer: Focus on opioid analgesics","volume":"15","author":"Leppert","year":"2011","journal-title":"Curr Pain Headache Rep"},{"key":"key20250513105852_b84-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"542","DOI":"10.21037\/apm.2019.12.09","article-title":"Combining opioids and benzodiazepines: Effects on mortality and severe adverse respiratory events","volume":"9","author":"Boon","year":"2020","journal-title":"Ann Palliat Med"},{"key":"key20250513105852_b85-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1111\/pme.12915","article-title":"Cardiac effects of opioid therapy","volume":"16 (Suppl 1)","author":"Chen","year":"2015","journal-title":"Pain Med"},{"issue":"e1384","key":"key20250513105852_b86-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1384","article-title":"mRNA vaccine in cancer therapy: Current advance and future outlook","volume":"13","author":"Li","year":"2023","journal-title":"Clin Transl Med"},{"key":"key20250513105852_b87-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.trecan.2019.05.010","article-title":"Integrative approaches to cancer immunotherapy","volume":"5","author":"Szeto","year":"2019","journal-title":"Trends Cancer"},{"issue":"176","key":"key20250513105852_b88-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00176","article-title":"Adoptive cell therapy targeting neoantigens: A frontier for cancer research","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"issue":"eaax0182","key":"key20250513105852_b89-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax0182","article-title":"Neoadjuvant checkpoint blockade for cancer immunotherapy","volume":"367","author":"Topalian","year":"2020","journal-title":"Science"},{"key":"key20250513105852_b90-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","article-title":"Immune mechanisms of toxicity from checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Trends Cancer"},{"issue":"184","key":"key20250513105852_b91-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"key20250513105852_b92-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"key20250513105852_b93-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr Oncol"},{"key":"key20250513105852_b94-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.chest.2018.08.1048","article-title":"Immune checkpoint immunotherapy for non-small cell lung cancer: Benefits and pulmonary toxicities","volume":"154","author":"Suresh","year":"2018","journal-title":"Chest"},{"key":"key20250513105852_b95-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/apt.13858","article-title":"Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis","volume":"45","author":"Acharya","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"key20250513105852_b96-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1097\/00000539-200006000-00028","article-title":"The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients","volume":"90","author":"Sacerdote","year":"2000","journal-title":"Anesth Analg"},{"key":"key20250513105852_b97-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"977","DOI":"10.6004\/jnccn.2019.0038","article-title":"Adult cancer pain, version 3.2019, NCCN clinical practice guidelines in oncology","volume":"17","author":"Swarm","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"key20250513105852_b98-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.2174\/1381612825666190717152226","article-title":"Opioid analgesics adverse effects: The other side of the coin","volume":"25","author":"Mercadante","year":"2019","journal-title":"Curr Pharm Des"},{"key":"key20250513105852_b99-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2023.0344","article-title":"Opioid-free anaesthesia","volume":"85","author":"Weir","year":"2024","journal-title":"Br J Hosp Med (Lond)"},{"issue":"e15375","key":"key20250513105852_b100-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015375","article-title":"Effects of systemic and neuraxial morphine on the immune system","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"key20250513105852_b101-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"7164","DOI":"10.1074\/jbc.M604367200","article-title":"Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"key20250513105852_b102-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.2147\/JPR.S158230","article-title":"Immune function after major surgical interventions: The effect of postoperative pain treatment","volume":"11","author":"Amodeo","year":"2018","journal-title":"J Pain Res"},{"issue":"e31167","key":"key20250513105852_b103-MCO-22-6-02848","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031167","article-title":"Morphine suppresses IFN signaling pathway and enhances AIDS virus infection","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"key20250513105852_b104-MCO-22-6-02848","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.intimp.2008.01.002","article-title":"Opioids modulate constitutive B-lymphocyte secretion","volume":"8","author":"Vassou","year":"2008","journal-title":"Int Immunopharmacol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T03:58:57Z","timestamp":1747108737000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2025.2848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":104,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,4,15]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2025.2848","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}